Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
60505-6282-7 · Carboplatin Injection · Teyro Labs
What is the package ndc for 60505-6282-7 · Carboplatin Injection · Teyro Labs?
For 60505-6282-7 · Carboplatin Injection · Teyro Labs, package ndc is 60505-6282-7; generic name is Carboplatin Injection; manufacturer is Teyro Labs; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.
"initial_posting_date": "04/28/2023", "package_ndc": "60505-6282-7", "generic_name": "Carboplatin Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d", "contact_info": "Apotex Inc.: 800-706-5575", "availability": "Unavailable", "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 60505-6282-7 verified
- Generic name
- Carboplatin Injection verified
- Manufacturer
- Teyro Labs verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug verified
- Initial posting date
- 04/28/2023 verified
- Last update date
- 08/18/2026 verified
- Days in shortage
- 1222 our reading
- Reason for shortage
- Discontinuation of the manufacture of the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Oncology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/18/2026", "therapeutic_category": [ "Oncology" ], "dosage_form": "Injection", "presentation": "Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)", "company_name": "Teyro Labs", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000